At a glance
ClinicalIndex Comparison RecordN/ACompleted· 296 enrolled
Drug / intervention
senofilcon A C3 +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Validation of Senofilcon A With New UV / HEV Filter
In Brief
A clinical study evaluating senofilcon A C3 and senofilcon A for Visual Acuity. Completed, enrolled 296 participants across 17 sites.
Detailed Summary
This is a bilateral, dispensing, randomized, controlled, subject-masked, 2-arm parallel study to evaluate safety and efficacy
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVisual Acuity
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartOct 2021
First PostedOct 2021
Primary CompletionNov 2021
TodayJul 2026
First PostedOct 29, 2021
Enrollment StartOct 5, 2021
Primary CompletionNov 24, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.7 years ago
Interventions
senofilcon A C3device
TEST Lens
senofilcon Adevice
CONTROL Lens